Literature DB >> 4025226

Is pain crisis a cause of death in sickle cell disease?

N A Parfrey, W Moore, G M Hutchins.   

Abstract

It has been a matter of controversy as to whether patients with sickle cell disease die of crisis or merely in crisis. The authors reviewed the 74 patients with sickle cell disease autopsied at The Johns Hopkins Hospital. From clinical review, there were 20 (27%) who died with pain crisis, 51 (69%) who died without pain crisis, and 3 (4%) for whom documentation was insufficient. On pathology review, death was attributable to infection in 19 (26%), uremia in 9 (12%), sequestration crisis in 9 (12%), necrotic bone marrow emboli in 7 (9%), and miscellaneous causes in 14 (19%); in 16 (22%) patients no cause of death could be identified. Death was explained in 47/51 (92%) patients without pain crisis; but only in 11/20 (55%, P less than 0.01) patients dying in pain crisis. The disproportionately large number of patients dying in pain crisis with an unexplained cause of death suggests that pain crisis may account for the death of some patients with sickle cell disease.

Entities:  

Mesh:

Year:  1985        PMID: 4025226     DOI: 10.1093/ajcp/84.2.209

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Tonsilectomy in sickle cell diseases.

Authors:  Mehmet Rami Helvaci; Cumali Gokce; Ramazan Davran; Can Acipayam; Seckin Akkucuk; Mustafa Ugur
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Sickle cell diseases and ileus.

Authors:  Mehmet Rami Helvaci; Akin Aydogan; Seckin Akkucuk; Cem Oruc; Mustafa Ugur
Journal:  Int J Clin Exp Med       Date:  2014-09-15

3.  Acute chest syndrome in severity of sickle cell diseases.

Authors:  Mehmet Rami Helvaci; Can Acipayam; Akin Aydogan; Seckin Akkucuk; Cem Oruc; Cumali Gokce
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease.

Authors:  Diana J Wilkie; Robert Molokie; Debra Boyd-Seal; Marie L Suarez; Young Ok Kim; Shiping Zong; Harriet Wittert; Zhongsheng Zhao; Yogen Saunthararajah; Zaijie J Wang
Journal:  J Natl Med Assoc       Date:  2010-01       Impact factor: 1.798

5.  Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.

Authors:  Roberto F Machado; A Kyle Mack; Sabrina Martyr; Christopher Barnett; Peter Macarthur; Vandana Sachdev; Inez Ernst; Lori A Hunter; Wynona A Coles; James P Nichols; Gregory J Kato; Mark T Gladwin
Journal:  Br J Haematol       Date:  2006-12-08       Impact factor: 6.998

6.  Autosplenectomy in severity of sickle cell diseases.

Authors:  Mehmet Rami Helvaci; Can Acipayam; Ramazan Davran
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 7.  Pulmonary hypertension in sickle cell disease: relevance to children.

Authors:  Gregory J Kato; Onyinye C Onyekwere; Mark T Gladwin
Journal:  Pediatr Hematol Oncol       Date:  2007 Apr-May       Impact factor: 1.969

8.  Autopsy findings and pattern of mortality in Nigerian sickle cell disease patients.

Authors:  Gabriel Olabiyi Ogun; Henry Ebili; Taiwo Racheal Kotila
Journal:  Pan Afr Med J       Date:  2014-05-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.